Nonetheless, ERα positive or over-expressed breast cancers associated with luminal A and B tumors [203,205] can transcriptionally target the MYC gene and deregulate MYC mRNA expression, independent of MYC amplification. The gene discussed is ESR1; the disease is breast carcinoma.